Similar Search Results

Payments, promotion, and the purple pill

Ridley, David B. - In: Health economics 24 (2015) 1, pp. 86-103

Persistent link: https://www.econbiz.de/10011316672

Herding versus hotelling : market entry with costly information

Ridley, David B. - In: Journal of economics & management strategy : JEMS 17 (2008) 3, pp. 607-631

Persistent link: https://www.econbiz.de/10003761200

Distance decreases with differentiation : strategic agglomeration by retailers

Picone, Gabriel A.; Ridley, David B.; Zandbergen, Paul A. - In: International journal of industrial organization 27 (2009) 3, pp. 463-473

Persistent link: https://www.econbiz.de/10003855050

Entry and competition in generic biologics

Grabowski, Henry G.; Ridley, David B.; Schulman, Kevin A. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 439-451

Persistent link: https://www.econbiz.de/10003543703

Commentary

Philipson, Tomas J. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 453-454

Persistent link: https://www.econbiz.de/10003543705

Would greater transparency and uniformity of health care prices benefit poor patients? : despite its surface appeal, price transparency can have negative effects on the poorest hea...

Kyle, Margaret K.; Ridley, David B. - In: Health affairs : at the intersection of health, health … 26 (2007) 5, pp. 1384-1391

Persistent link: https://www.econbiz.de/10003561857

Innovation incentives under transferable fast-track regulatory review

Gans, Joshua; Ridley, David B. - In: The journal of industrial economics 61 (2013) 3, pp. 789-816

Persistent link: https://www.econbiz.de/10010241487

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - 2013

Persistent link: https://www.econbiz.de/10010200106

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - In: International journal of industrial organization 31 (2013) 5, pp. 538-553

Persistent link: https://www.econbiz.de/10010248454

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - 2013

We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and "me-too" drugs each increased...

Persistent link: https://www.econbiz.de/10010250679